Cite
HARVARD Citation
Schuster, F. et al. (n.d.). Immunotherapy with the trifunctional anti‐CD20 x anti‐CD3 antibody FBTA05 (Lymphomun) in paediatric high‐risk patients with recurrent CD20‐positive B cell malignancies. British journal of haematology. pp. 90-102. [Online].